Animal studies have revealed no teratogenic, embryotoxic or fetotoxic effects. There are no controlled data in human pregnancy. AU...
Hidradenitis suppurativa (HS) HUMIRA
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) reported top-line results from a phase 3 trial involving their experimental drug sarilumab earlier...
AbbVie Receives Orphan Drug Designation for HUMIRA® (adalimumab) from the U.S. Food and Drug Administration for the Investigational Treatment...
Hidradenitis suppurativa (HS) Non-Profit (501c3) 2017 Registration
We are currently fundraising for the Non-Profit (501c3) registration of HSAWARENESS.ORG and our growing NGO at large. We cannot realize this next and essential step for our critical work without you.
“I WILL NOT HIDE” Hidradenitis suppurativa (HS) Patient Stories Book Series
The “I WILL NOT HIDE” Hidradenitis Suppurativa book series is now available. These patient story volumes tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by HS patients themselves.
HSAWARENESS EMAIL UPDATES